260 related articles for article (PubMed ID: 22713616)
21. [Unfractionated heparin and low molecular weight heparin for acute coronary syndromes--assessment of a Cochrane review].
Husted SE; Nielsen HK
Ugeskr Laeger; 2010 Sep; 172(37):2522-6. PubMed ID: 20836961
[TBL] [Abstract][Full Text] [Related]
22. Thromboprophylaxis in medical-surgical critically ill patients.
Crowther MA; Cook DJ
Curr Opin Crit Care; 2008 Oct; 14(5):520-3. PubMed ID: 18787443
[TBL] [Abstract][Full Text] [Related]
23. Ximelagatran for prevention and treatment of venous thromboembolism.
Kwok L; Boucher M
Issues Emerg Health Technol; 2004 Jun; (57):1-4. PubMed ID: 15214359
[TBL] [Abstract][Full Text] [Related]
24. Venous thromboembolism in the ICU and reversal of bleeding on anticoagulants.
DeLoughery TG
Crit Care Clin; 2005 Jul; 21(3):497-512. PubMed ID: 15992670
[TBL] [Abstract][Full Text] [Related]
25. Evolution of heparin anticoagulants to ultra-low-molecular-weight heparins: a review of pharmacologic and clinical differences and applications in patients with cancer.
Walenga JM; Lyman GH
Crit Rev Oncol Hematol; 2013 Oct; 88(1):1-18. PubMed ID: 23849978
[TBL] [Abstract][Full Text] [Related]
26. Low-dose fondaparinux in suspected heparin-induced thrombocytopenia in the critically ill.
Wester JP; Leyte A; Oudemans-van Straaten HM; Bosman RJ; van der Spoel JI; Haak EA; Porcelijn L; Zandstra DF
Neth J Med; 2007 Mar; 65(3):101-8. PubMed ID: 17387236
[TBL] [Abstract][Full Text] [Related]
27. Management of anticoagulation in the critically ill patient.
Toale KM
Crit Care Nurs Clin North Am; 2013 Dec; 25(4):471-80, vi. PubMed ID: 24267283
[TBL] [Abstract][Full Text] [Related]
28. New oral anticoagulants in venous thromboembolism prophylaxis in orthopaedic patients: are they really better?
Huo MH
Thromb Haemost; 2011 Jul; 106(1):45-57. PubMed ID: 21544312
[TBL] [Abstract][Full Text] [Related]
29. Thromboembolism.
Fitzmaurice D; Hobbs FD; McManus R
Clin Evid; 2002 Jun; (7):199-213. PubMed ID: 12230644
[No Abstract] [Full Text] [Related]
30. Extended-duration low-molecular-weight heparin prophylaxis following total joint arthroplasty.
Whang PG; Lieberman JR
Am J Orthop (Belle Mead NJ); 2002 Sep; 31(9 Suppl):31-6. PubMed ID: 12349893
[TBL] [Abstract][Full Text] [Related]
31. Heparin and low molecular weight heparin in thrombosis and beyond.
Mousa SA
Curr Opin Investig Drugs; 2002 Aug; 3(8):1181-6. PubMed ID: 12211411
[TBL] [Abstract][Full Text] [Related]
32. Dalteparin versus unfractionated heparin in critically ill patients.
; Cook D; Meade M; Guyatt G; Walter S; Heels-Ansdell D; Warkentin TE; Zytaruk N; Crowther M; Geerts W; Cooper DJ; Vallance S; Qushmaq I; Rocha M; Berwanger O; Vlahakis NE
N Engl J Med; 2011 Apr; 364(14):1305-14. PubMed ID: 21417952
[TBL] [Abstract][Full Text] [Related]
33. Current use of low molecular weight heparins.
Donayre CE
Semin Vasc Surg; 1996 Dec; 9(4):362-71. PubMed ID: 8958613
[No Abstract] [Full Text] [Related]
34. [Heparins, antivitamins K. Principles and rules of use. Posology of non-fractionated heparins].
Delsart D; Chambefort V; Decousus H
Rev Prat; 2001 Sep; 51(13):1489-97. PubMed ID: 11601082
[No Abstract] [Full Text] [Related]
35. Activated partial thromboplastin time monitoring in patients receiving unfractionated heparin for venous thromboembolism in relation to clinical outcomes.
Vardi M; Laor A; Bitterman H
Thromb Haemost; 2009 Nov; 102(5):879-86. PubMed ID: 19888523
[TBL] [Abstract][Full Text] [Related]
36. [Cancer, thromboembolia and antithrombotic therapy: is there an anticoagulant of choice?].
Scharf RE
Dtsch Med Wochenschr; 2011 Nov; 136(47):2403. PubMed ID: 22094968
[No Abstract] [Full Text] [Related]
37. Role of heparin and low-molecular-weight heparins in the management of acute ischemic stroke.
Padma V; Fisher M; Moonis M
Expert Rev Cardiovasc Ther; 2006 May; 4(3):405-15. PubMed ID: 16716101
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of anticoagulant prophylaxis to prevent venous thromboembolism in acutely ill medical inpatients: a meta-analysis.
Själander A; Jansson JH; Bergqvist D; Eriksson H; Carlberg B; Svensson P
J Intern Med; 2008 Jan; 263(1):52-60. PubMed ID: 18088252
[TBL] [Abstract][Full Text] [Related]
39. Low molecular weight heparins (LMWH) in the treatment of patients with acute venous thromboembolism.
Hirsh J; Siragusa S; Cosmi B; Ginsberg JS
Thromb Haemost; 1995 Jul; 74(1):360-3. PubMed ID: 8578485
[TBL] [Abstract][Full Text] [Related]
40. The treatment of venous thromboembolism in patients with cancer.
Prandoni P
Intern Emerg Med; 2010 Oct; 5 Suppl 1():S27-30. PubMed ID: 20865471
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
